查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1847197

中國牙科移植骨替代物市場：市場規模、佔有率和趨勢分析（2025-2031年）

Dental Bone Graft Substitutes Market Size, Share & Trends Analysis | China | 2025-2031 | Includes: Dental Barrier Membranes, Antimicrobial Periodontal Treatment, and 2 more
出版日期: | 出版商: iData Research Inc. | 英文 81 Pages | 商品交期: 最快1-2個工作天內

價格
如有價格方面的疑問請按下「詢問」鍵來信查詢

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024 年中國牙科移植骨替代物（DBGS）和其他生醫材料市場規模約為 2.64 億美元，預計到 2031 年將達到約 6.9 億美元，年複合成長率為 14.7%。

本報告涵蓋牙科移植骨替代物、牙科屏障膜、局部抗菌牙周治療、牙科軟組織傷口護理。這些類別統稱為牙科生醫材料市場。本研究量化了銷售量、平均售價 (ASP)、市場規模、成長率和企業市場占有率。此外，報告還分析了市場趨勢和促進因素、近期併購活動、技術和實踐趨勢以及競爭策略。報告提供截至 2021 年的歷史數據，並預測至 2031 年。

中國是牙科生醫材料市場成長最快的地區之一。推動這一成長的因素包括人工植牙手術數量的增加、消費者對再生牙科認知度的提高以及同種異體和異種移植材料的接受度不斷提高。雖然合成材料仍然很重要，但同種異體和異質骨移植領域正在迅速擴張，重塑產品組合和定價模式。

市場概覽

隨著植入在私人診所和醫院的普及，中國牙科生醫材料市場正在快速擴張。中階的壯大、牙科醫療服務的可及性提高以及對先進修復技術的投入，都推動了對可預測的骨骼和軟組織再生材料的需求。

成長最快的生醫材料是牙科移植骨替代物。尤其值得注意的是，同種異體移植和異質骨移植材料的市佔率成長速度超過了合成材料。這一轉變反映了臨床對生物移植材料日益成長的信心以及患者接受度的提高。同時，符合各國監管要求的本地供應商的出現，也使得這些材料更易於取得且價格更實惠。

隨著臨床醫生對引導性骨骼和組織再生術的通訊協定進行標準化，屏障膜的應用日益普及。隨著訓練的普及，越來越多的臨床醫生將植骨材料與可吸收膜和不可吸收膜結合使用，以改善治療效果並減少再次植骨手術。抗菌牙周治療和軟組織創傷護理產品透過支持感染控制和促進癒合，完善了整個治療生態系統。

市場成長仍然對監管流程和定價非常敏感。國家食品藥物管理局（CFDA）的要求、診所預算和私人醫療模式都會影響產品的選擇和時機。儘管如此，由於植入使用案例的增加、教育的普及以及同種異體和異質骨移植在日常實踐中的應用日益規範化，長期前景仍然光明。

市場促進因素

人工植牙治療的發展

大多數骨移植手術都應用於植入病例。隨著植入數量的增加，能夠從骨移植中獲益​​的患者數量也隨之增加。雖然並非所有植入都需要骨移植，但許多植牙部位存在需要改善體積或輪廓的骨缺損。植入與骨移植之間的這種聯繫，使得骨移植材料的需求持續穩定。

蓋氏利希的全球品牌認知度

蓋斯特利希是再生材料領域公認的領導者。其卓越的聲譽和悠久的臨床歷史讓中國牙醫和患者倍感安心。這種信任促使臨床醫生在需要穩定操作和可預測結果的情況下採用異質骨移植產品。隨著時間的推移，人們對蓋斯特利希產品系列的熟悉程度不斷加深，最終促成了異質骨移植在部分自體牙修復的廣泛應用。

消費者對異質骨移植產品的接受度

教育、同儕審查出版物和科學活動正在提高人們對同種異體移植材料的接受度。隨著觀念的轉變，市場正在形成區域性組織庫，並建立更清晰的供應管道。這減少了某些適應症對自體骨的依賴，並為更標準化的再生方案鋪平了道路。

培訓和臨床教育

教育促進技術應用。實作課程與學習小組教授臨床醫師材料選擇、植骨幾何形狀、膜放置等知識。隨著從業者經驗的積累，他們更有可能將植骨技術納入植入計畫和牙周治療方案中。培訓有助於提高種植成功率和復診率。

豐富的產品選擇和組合套餐

診所傾向於簡化採購流程。供應商若能提供包含植皮、膜、抗菌墊片和創傷護理產品的全套產品組合，可降低訂購的複雜性。捆綁式產品也有助於維持臨床工作流程的一致性。隨著產品組合的擴展，膜及相關產品以及DBGS材料的使用量可望增加。

市場限制

改善口腔衛生

口腔衛生和預防保健的改善將隨著時間的推移減少對複雜修復程序的需求，即使老年人口不斷成長，這一趨勢也可能減緩 DBGS 和膜基程序的成長速度。

成本與公共衛生系統

如果患者沒有醫療保險補貼，使用生醫材料的大型牙科手術通常需要自費。價格敏感性可能導致治療延誤或選擇價格較低的材料。這種影響在主要城市中心以外的地區更為顯著。

嚴格的法規環境

在中國銷售的產品須遵守國家食品藥品監督管理總局（CFDA）的規定。外國製造商通常需要完成本地臨床試驗並經過詳細的註冊流程。這些程序可能會延遲產品上市，並限制特定品類中的品牌數量，導致市場進入成本高且週期漫長。

疾病傳播風險

一些從業者對人源和動物源性材料持謹慎態度。有關組織來源和感染疾病的報道，即使與牙科用途無關，也​​會影響臨床醫生和患者的選擇。這種持續的謹慎促使一些牙科診所轉向人工牙或自體牙。

目標市場和數據範圍

  • 定量覆蓋範圍：市場規模、市場佔有率、市場預測、成長率、銷售量、平均售價。
  • 定性內容：成長趨勢、市場限制、競爭分析和主要競爭對手的 SWOT 分析、併購、公司簡介、產品系列、顛覆性技術、影響需求的疾病概述。
  • 時段：基準年為 2024 年，預測至 2031 年，歷史資料為 2021 年至 2023 年。
  • 資料來源：對行業領導者的直接訪談、政府醫生和監管資料、醫院和私人診所資料、進出口記錄、iData Research 內部資料庫。
  • 方法說明：收入模型以單位數量乘以平均售價 (ASP) 計算。模型檢驗採用不同醫療機構的手術量、使用率數據和經銷商回饋。

醫療機構包括公立醫院、私人醫院、學術牙科中心和私人牙科診所。

目標市場及區隔

牙科移植骨替代物（DBGS）

  • 依類型：同種異體移植、異質骨移植、合成移植

牙科屏障膜

  • 依類型：可吸收、不可吸收
  • 依材料分類：同種異體移植、異質骨移植、複合材料。

抗菌牙周治療

局部抗菌治療用於減少牙周袋內的細菌負荷並促進癒合。

牙科軟組織傷口護理

  • 依類型：塞子、膠帶、泡沫

本部分僅進行單元層面的分析。

每個子類別包括市場價值、銷售、平均售價、預期成長率和競爭格局（如適用）。

競爭分析

2024年，蓋斯特利希在蓬勃發展的異質骨移植市場中佔領先地位。蓋斯特利希的全球聲譽和臨床成功案例贏得了臨床醫生的信賴。透過在中國設立本地子公司，蓋斯特利希有效克服了文化和溝通障礙，提升了服務水平，並提高了品牌知名度。隨著異種移植應用的日益普及，蓋斯特利希憑藉其本地化佈局和持續的培訓，將繼續保持其市場領先地位。

山西歐斯瑞德在獲得國家食品藥品監督管理總局（CFDA）批准後，迅速在同種異體移植材料領域佔主導地位。由於監管嚴格，國內同種異體移植材料供應商數量仍有限。許多國際同種異體移植材料品牌尚未進入中國市場，這進一步鞏固了國內核准供應商的競爭優勢。憑藉這一供應優勢和對產品領域的專注，山西歐斯瑞德在2024年位列生物材料市場（DBGS）和整體生醫材料市場第二名。

德士製藥 (Dexcel Pharma) 在 2024 年整體排名中位列第三，主要得益於其在局部抗菌牙周治療領域的領先地位。該公司的 PerioChip® 產品含有 2.5 毫克洛赫西定洛赫西定定，裝在一個小型可生物分解的植入物中，專為置入牙周袋而設計。廣泛的臨床經驗和完善的操作規範支持了該產品在包括中國在內的亞太地區的穩定使用。

各個價格分佈和材料類型的競爭都異常激烈。國際品牌強調臨床傳承和培訓，而本土企業則強調符合監管要求、在地化支援和成本控制。這種格局既有利於持續成長，也提高了品質系統、實證醫學證據和上市後措施的標準。

科技與臨床趨勢

  • 同種異體移植和異種移植的快速成長：由於人們認為這些移植材料具有良好的生物性能和易於操作，它們正在領先合成材料獲得市場佔有率。
  • GBR 和 GTR 的標準化：臨床醫生擴大將移植物與可吸收或不可吸收膜結合使用，以提高穩定性和形狀保持能力。
  • 注重安全性和加工流程：無菌性、來源透明和文件記錄是產品選擇的核心。清晰的標籤和培訓可以減少混淆。
  • 產品組合捆綁銷售：供應商正在推廣包含移植片、膜和創傷護理用品的整合套件，以簡化病例計劃和採購。
  • 縮短就診時間：易於使用且能減少操作時間的產品更容易被採用，尤其是在就診量大的診所。
  • 教育和指導：學習小組和現場課程將加速可預測的、分階段的重建通訊協定在主要城市以外的地區推廣。

地區

本期內容主要涉及中國。

為什麼要寫這份報告？

中國牙科生醫材料市場中最大、成長最快的機會在哪裡？

同種異體移植和異質骨移植比例的變化將如何影響定價、培訓和供應商佔有率？

牙周病治療中成長最快的屏障膜和抗菌劑及其原因。

CFDA 的要求和臨床試驗需求將如何影響市場進入和產品上市時間表？

成長面臨的主要風險有哪些？例如，疾病傳播和自付費用等方面的擔憂？

供應商應如何整合產品組合以改善交叉銷售並簡化診所工作流程？

哪些教育和服務模式可以幫助診所採用可預測的GBR和GTR通訊協定？

商業團隊如何規劃以因應不同地區在價格敏感度和產品組合上的差異？

iData Research 的「中國牙科骨移植片替代物及其他生醫材料市場報告」透過程序模型、定價細節和企業市場占有率分析來回答這些問題。

利用這份報告，可以依類別量化需求，規劃產品發布，設定定價和合約目標，並將培訓和支援與快速成長的區隔市場相匹配。

目錄

圖表清單

圖表列表

調查方法

全球關稅的影響

中國牙科移植骨替代物及其他生醫材料市場

  • 摘要整理
    • 中國牙科移植骨替代物及其他生醫材料市場概覽
    • 競爭分析
    • 市場趨勢
    • 流程分段
    • 市場區隔
  • 介紹
    • 牙科骨移植替代物
    • 牙科屏障膜
    • 局部抗菌牙周治療
  • 手術次數
    • 齒槽骨移植手術
  • 單元分析
    • 依手術類型分類的牙科骨移植替代材料銷售情況
    • 牙科屏障膜單元（依尺寸）
  • 外匯
  • 市場概覽
  • 市場分析與預測
    • 牙科骨移植替代物市場
    • 牙科屏障膜市場
    • 抗菌牙周病治療市場
    • 牙科軟組織創傷護理市場
  • 推動和阻礙因素
  • 競爭市佔率分析
    • 牙科骨移植替代材料市場競爭格局分析
    • 牙科屏障膜市場競爭格局及市場佔有率分析
    • 抗菌牙周治療市場競爭市佔率分析

簡稱

Product Code: iDATA_CNDBGS25_MS

The Chinese dental bone graft substitute (DBGS) and other biomaterials market was valued at nearly $264 million in 2024. It is expected to grow at a compound annual growth rate of 14.7% to reach almost $690 million by 2031.

This report covers dental bone graft substitutes, dental barrier membranes, local antimicrobial periodontal treatments, and dental soft tissue wound care. Together, these categories are referred to as the dental biomaterials market. The study quantifies unit sales, average selling prices (ASPs), market size, growth rates, and company shares. It also analyzes market drivers and limiters, recent mergers and acquisitions, technology and practice trends, and competitive strategies. The report includes historical data to 2021 and forecasts to 2031.

China is one of the fastest growing markets for dental biomaterials. Growth is supported by higher dental implant procedure volumes, rising consumer awareness of regenerative dentistry, and increased acceptance of allograft and xenograft materials. While synthetic materials remain relevant, the allograft and xenograft segments are expanding faster, which is reshaping product mix and pricing dynamics.

Market Overview

The Chinese dental biomaterials market is scaling quickly as implant dentistry becomes more common in private clinics and hospital departments. A growing middle class, wider access to dental care, and investment in advanced restorative procedures are raising the demand for predictable bone and soft tissue regeneration.

The strongest growth within biomaterials is in dental bone graft substitutes. In particular, allograft and xenograft segments are expanding faster than synthetic materials. This change reflects growing clinical confidence in biologic grafts and improved patient acceptance. The shift also aligns with the introduction of local suppliers that meet national regulatory requirements, which helps with availability and pricing.

Barrier membranes are also gaining traction as clinicians standardize guided bone regeneration and guided tissue regeneration protocols. As training expands, more providers are pairing grafts with resorbable and non-resorbable membranes to improve outcomes and reduce reentry procedures. Antimicrobial periodontal treatments and soft tissue wound care products round out the ecosystem by supporting infection control and healing.

Market growth remains sensitive to regulatory processes and pricing. CFDA requirements, clinic budgets, and out-of-pocket payment models influence what products are selected and when. Even so, the long-term outlook is positive due to an increasing number of implant cases, broader education, and the normalization of allograft and xenograft use in everyday practice.

Market Drivers

Growth of Dental Implant Procedures

Most DBGS procedures occur with implant cases. As the number of implants rises, the pool of patients who can benefit from grafting grows as well. Not every implant requires a graft, but many sites have defects that need volume or contour improvement. This link between implant placement and bone grafting supports steady demand for DBGS materials.

Geistlich's Global Brand Recognition

Geistlich is a recognized leader in regenerative materials. Its reputation and long clinical history help reassure dentists and patients in China. This trust encourages adoption of xenograft products in cases where clinicians seek consistent handling and predictable outcomes. Over time, familiarity with Geistlich's portfolio has supported a wider use of xenografts in place of some autogenous options.

Consumer Acceptance of Allograft Products

Acceptance of allograft materials has improved due to education, peer-reviewed publications, and conference activity. As perception shifts, the market has seen the formation of regional tissue banks and a clearer supply pathway. This has reduced reliance on autogenous bone in select indications and opened the door for more standardized regenerative protocols.

Training and Clinical Education

Education drives utilization. Hands-on courses and study clubs teach clinicians how to select materials, shape grafts, and place membranes. As providers gain experience, they are more likely to integrate grafting into implant plans and periodontal treatment paths. Training supports higher success rates and repeat adoption.

Broader Product Choice and Portfolio Bundling

Clinics prefer streamlined purchasing. Suppliers that offer grafts, membranes, antimicrobial inserts, and wound care in one portfolio can reduce ordering complexity. Bundled offerings also support consistent clinical workflows. As portfolios expand, adoption of membranes and related products tends to rise alongside DBGS materials.

Market Limiters

Improvements in Dental Health

Better oral hygiene and preventive care reduce the need for complex restorative work over time. This trend can slow the growth rate of procedures that use DBGS and membranes, even as the older population grows.

Costs and the Public Health System

Major dental procedures that use biomaterials are generally paid out of pocket if patients do not carry supplemental coverage. Price sensitivity can delay treatment or steer choices to lower cost materials. This effect is stronger outside large urban centers.

Strict Regulatory Environment

Products sold in China are subject to CFDA requirements. Foreign manufacturers often need to complete local clinical studies and navigate a detailed registration process. These steps can delay product launches and limit the number of available brands in select categories. As a result, market entry costs are higher and timelines are longer.

Risk of Disease Transmission

Some practitioners remain cautious about human or animal-derived materials. Reports about tissue sourcing or infection can influence clinician and patient choices, even when unrelated to dental use. Persistent caution can shift usage toward synthetic or autogenous options in some clinics.

Market Coverage and Data Scope

  • Quantitative coverage: Market size, market shares, market forecasts, growth rates, units sold, and ASPs.
  • Qualitative coverage: Growth trends, market limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles, product portfolios, disruptive technologies, and disease overviews that shape demand.
  • Time frame: Base year 2024, forecasts to 2031, historical data from 2021 to 2023.
  • Data sources: Primary interviews with industry leaders, government physician and regulatory data, hospital and private clinic data, import and export records, and the iData Research internal database.
  • Method note: Revenue is modeled as units multiplied by ASP. Models are validated with procedure volumes, utilization inputs, and distributor feedback across care settings.

Care settings include public hospitals, private hospitals, academic dental centers, and private dental clinics.

Markets Covered and Segmentation

Dental Bone Graft Substitutes (DBGS)

  • By type: Allografts, xenografts, synthetics.

Dental Barrier Membranes

  • By type: Resorbable, non-resorbable.
  • By material: Allografts, xenografts, synthetics.

Antimicrobial Periodontal Treatment

Local antimicrobial therapies used to reduce bacterial load and support healing in periodontal pockets.

Dental Soft Tissue Wound Care

  • By type: Plug, tape, foam.

This segment is analyzed at a unit level only.

Each subcategory includes market values, unit volumes, ASPs, and forecast growth, along with competitive context where applicable.

Competitive Analysis

Geistlich led the expanding xenograft market in 2024. The company's global reputation and documented clinical track record support strong clinician trust. By establishing a local affiliate in China, Geistlich addressed cultural and communication barriers, enhanced service levels, and increased brand awareness. This local presence, combined with ongoing education, positions Geistlich to keep its leadership as xenograft usage grows.

Shanxi OsteoRad held a leading position in the allograft category after gaining CFDA approval for its products. Due to strict regulation, the number of allograft suppliers in China remains limited. Many international allograft brands have not yet entered the market, which strengthens the competitive stance of approved domestic providers. Shanxi OsteoRad ranked second in the overall DBGS and biomaterials market in 2024 due to this supply position and category focus.

Dexcel Pharma ranked third overall in 2024, supported by leadership in local antimicrobial periodontal treatment. Its PerioChip(R) product contains 2.5 mg chlorhexidine digluconate in a small biodegradable insert designed for placement into periodontal pockets. Broad clinical familiarity with chlorhexidine and established handling protocols support stable usage across Asia Pacific, including China.

Competition is active across price tiers and material types. International brands emphasize clinical heritage and training, while domestic firms focus on regulatory alignment, localized support, and cost control. This structure supports continued growth but also raises the bar for quality systems, evidence, and post-market engagement.

Technology and Practice Trends

  • Faster growth in allograft and xenograft: These categories are gaining share ahead of synthetics due to perceived biological performance and handling.
  • Standardization of GBR and GTR: More clinicians pair grafts with resorbable or non-resorbable membranes to improve stability and shape maintenance.
  • Focus on safety and processing: Sterilization, sourcing transparency, and documentation are central to product selection. Clear labeling and training reduce hesitation.
  • Portfolio bundling: Suppliers promote integrated kits that include grafts, membranes, and wound care items to streamline case planning and purchasing.
  • Chair-time efficiency: Products that handle well and reduce surgical time support adoption, especially in high-volume clinics.
  • Education and mentorship: Study clubs and live courses accelerate the spread of predictable, stepwise regenerative protocols beyond major cities.

Geography

This edition covers China.

Why This Report

Where are the largest and fastest-growing opportunities within China's dental biomaterials market.

How will the mix shift toward allograft and xenograft affect pricing, training, and supplier share.

Which barrier membranes and periodontal antimicrobials are expanding most quickly and why.

How do CFDA requirements and clinical study needs affect market entry and product timelines.

What are the key risks to growth, including disease transmission concerns and out-of-pocket costs.

How should suppliers bundle portfolios to improve cross-selling and simplify clinic workflows.

What education and service models help clinics adopt predictable GBR and GTR protocols.

How can commercial teams plan for regional differences in price sensitivity and product mix.

The China Dental Bone Graft Substitute and Other Biomaterials Market Report from iData Research answers these questions with procedure-aware models, pricing detail, and company share analysis.

Use it to quantify demand by category, plan product launches, set pricing and contracting targets, and align training and support with the fastest growing segments.

TABLE OF CONTENT

Table Of Contents

List Of Figures

List Of Charts

Research Methodology

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems And Perform Secondary Research
  • Step 3: Preparation For Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast And Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review And Market Release
  • Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

China Dental Bone Graft Substitute and Other Biomaterials Market

  • 8.1 Executive Summary
    • 8.1.1 China Dental Bone Graft Substitute and Other Biomaterials Market Overview
    • 8.1.2 Competitive Analysis
    • 8.1.3 Market Trends
    • 8.1.4 Procedure Segmentation
    • 8.1.5 Market Segmentation
  • 8.2 Introduction
    • 8.2.1 Dental Bone Graft Substitutes
      • 8.2.1.1 Autografts
      • 8.2.1.2 Allografts
      • 8.2.1.2.1 Mineralized Allografts
      • 8.2.1.2.2 Demineralized Bone Matrix
      • 8.2.1.3 Xenografts
      • 8.2.1.4 Synthetics
    • 8.2.2 Dental Barrier Membranes
    • 8.2.3 Local Antimicrobial Periodontal Treatment
  • 8.3 Procedure Numbers
    • 8.3.1 Dental Bone Grafting Procedures
  • 8.4 Unit Analysis
    • 8.4.1 Dental Bone Graft Substitute Units Sold by Procedure Type
    • 8.4.2 Dental Barrier Membrane Units Sold by Size
      • 8.4.2.1 Resorbable Dental Barrier Membrane Units Sold by Size
      • 8.4.2.2 Non-Resorbable Dental Barrier Membrane Units Sold by Size
  • 8.5 Currency Exchange Rate
  • 8.6 Market Overview
  • 8.7 Market Analysis and Forecast
    • 8.7.1 Dental Bone Graft Substitute Market
      • 8.7.1.1 Allograft Market
      • 8.7.1.2 Xenograft Market
      • 8.7.1.3 Synthetic Market
    • 8.7.2 Dental Barrier Membrane Market
      • 8.7.2.1 Dental Barrier Membrane Market by Segment
      • 8.7.2.1.1 Allograft Dental Barrier Membrane Market
      • 8.7.2.1.2 Xenograft Dental Barrier Membrane Market
      • 8.7.2.1.3 Synthetic Dental Barrier Membrane Market
      • 8.7.2.2 Dental Barrier Membrane Market by Material
      • 8.7.2.2.1 Resorbable Dental Barrier Membrane Market
      • 8.7.2.2.2 Non-Resorbable Dental Barrier Membrane Market
    • 8.7.3 Antimicrobial Periodontal Treatment Market
    • 8.7.4 Dental Soft Tissue Wound Care Market
      • 8.7.4.1 Dental Wound Care Plugs Market
      • 8.7.4.2 Dental Wound Care Tape Market
      • 8.7.4.3 Dental Wound Care Foam Market
  • 8.8 Drivers and Limiters
    • 8.8.1 Market Drivers
    • 8.8.2 Market Limiters
  • 8.9 Competitive Market Share Analysis
    • 8.9.1 Dental Bone Graft Substitute Market Competitive Market Share Analysis
    • 8.9.2 Dental Barrier Membrane Market Competitive Market Share Analysis
    • 8.9.3 Antimicrobial Periodontal Treatment Market Competitive Market Share Analysis

Abbreviations

LIST OF CHARTS

  • Chart 8-1: Dental Bone Graft Substitute and Other Biomaterials by Segment, China, 2024
  • Chart 8-2: Dental Bone Graft Substitute and Other Biomaterials Market Overview, China, 2024 & 2031
  • Chart 8-3: Dental Bone Grafting Procedures by Segment, China, 2021 - 2031
  • Chart 8-4: Dental Bone Graft Substitute and Other Biomaterials Market by Segment, China, 2021 - 2031
  • Chart 8-5: Leading Competitors, Dental Bone Graft Substitute and Other Biomaterials Market, China, 2024

LIST OF FIGURES

  • Figure 8-1: Dental Bone Graft Substitute and Other Biomaterials Market Share Ranking by Segment, China, 2024
  • Figure 8-2: Factors Impacting the Dental Bone Graft Substitute and Other Biomaterials Market by Segment, China
  • Figure 8-3: Dental Bone Graft Substitute and Other Biomaterials Procedure Segmentation, China
  • Figure 8-4: Dental Bone Graft Substitute and Other Biomaterials Market Segmentation, China
  • Figure 8-5: Dental Bone Grafting Procedures and Penetration Rates by Segment, China, 2021 - 2031
  • Figure 8-6: Dental Bone Graft Procedure Numbers and Volume Usage by Application, China, 2021 - 2031 (1 of 2)
  • Figure 8-7: Dental Bone Graft Procedure Numbers and Volume Usage by Application, China, 2021 - 2031 (2 of 2)
  • Figure 8-8: Dental Bone Graft Units Sold by Procedure, China, 2021 - 2031
  • Figure 8-9: Resorbable Dental Barrier Membrane Units Sold by Size, China, 2021 - 2031
  • Figure 8-10: Non-Resorbable Dental Barrier Membrane Units Sold by Size, China, 2021 - 2031
  • Figure 8-11: Currency Exchange Rate, 2024
  • Figure 8-12: Dental Bone Graft Substitute and Other Biomaterials Market by Segment, China, 2021 - 2031 (US$M)
  • Figure 8-13: Dental Bone Graft Substitute and Other Biomaterials Market by Segment, China, 2021 - 2031 (CH¥M)
  • Figure 8-14: Total Dental Bone Graft Substitute Market, China, 2021 - 2031
  • Figure 8-15: Dental Bone Graft Substitute Market by Segment, China, 2021 - 2031 (US$M)
  • Figure 8-16: Dental Bone Graft Substitute Market by Segment, China, 2021 - 2031 (CH¥M)
  • Figure 8-17: Allograft Market, China, 2021 - 2031
  • Figure 8-18: Xenograft Market, China, 2021 - 2031
  • Figure 8-19: Synthetic Market, China, 2021 - 2031
  • Figure 8-20: Total Dental Barrier Membrane Market, China, 2021 - 2031
  • Figure 8-21: Dental Barrier Membrane Market by Segment, China, 2021 - 2031 (US$M)
  • Figure 8-22: Dental Barrier Membrane Market by Segment, China, 2021 - 2031 (CH¥M)
  • Figure 8-23: Allograft Dental Barrier Membrane Market, China, 2021 - 2031
  • Figure 8-24: Xenograft Dental Barrier Membrane Market, China, 2021 - 2031
  • Figure 8-25: Bovine Xenograft Dental Barrier Membrane Market, China, 2021 - 2031
  • Figure 8-26: Porcine Xenograft Dental Barrier Membrane Market, China, 2021 - 2031
  • Figure 8-27: Synthetic Dental Barrier Membrane Market, China, 2021 - 2031
  • Figure 8-28: Dental Barrier Membrane Market by Material, China, 2021 - 2031 (US$M)
  • Figure 8-29: Dental Barrier Membrane Market by Material, China, 2021 - 2031 (CH¥M)
  • Figure 8-30: Resorbable Dental Barrier Membrane Market, China, 2021 - 2031
  • Figure 8-31: Non-Resorbable Dental Barrier Membrane Market, China, 2021 - 2031
  • Figure 8-32: Non-Reinforced Non-Resorbable Dental Barrier Membrane Market, China, 2021 - 2031
  • Figure 8-33: Titanium-Reinforced Non-Resorbable Dental Barrier Membrane Market, China, 2021 - 2031
  • Figure 8-34: Total Antimicrobial Periodontal Treatment Market, China, 2021 - 2031
  • Figure 8-35: Dental Wound Care Market by Type, China, 2021 - 2031 (US$M)
  • Figure 8-36: Dental Wound Care Market by Type, China, 2021 - 2031 (CH¥M)
  • Figure 8-37: Dental Soft Tissue Wound Care Market, China, 2021 - 2031
  • Figure 8-38: Dental Wound Care Plugs Market, China, 2021 - 2031
  • Figure 8-39: Dental Wound Care Tape Market, China, 2021 - 2031
  • Figure 8-40: Dental Wound Care Foam Market, China, 2021 - 2031
  • Figure 8-41: Leading Competitors, Dental Bone Graft Substitute and Other Biomaterials Market, China, 2024
  • Figure 8-42: Leading Competitors, Dental Bone Graft Substitute Market, China, 2024
  • Figure 8-43: Leading Competitors, Dental Barrier Membrane Market, China, 2024
  • Figure 8-44: Leading Competitors, Antimicrobial Periodontal Treatment Market, China, 2024